These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20352464)

  • 21. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.
    Zargar H; Shah JB; van Rhijn BW; Daneshmand S; Bivalacqua TJ; Spiess PE; Black PC; Kassouf W;
    J Urol; 2018 Jun; 199(6):1452-1458. PubMed ID: 29329894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.
    Yeshchina O; Badalato GM; Wosnitzer MS; Hruby G; RoyChoudhury A; Benson MC; Petrylak DP; McKiernan JM
    Urology; 2012 Feb; 79(2):384-90. PubMed ID: 22196406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.
    How J; Blattner M; Fowler S; Wang-Gillam A; Schindler SE
    Neurologist; 2016 Nov; 21(6):112-117. PubMed ID: 27801773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
    Siefker-Radtke AO; Dinney CP; Shen Y; Williams DL; Kamat AM; Grossman HB; Millikan RE
    Cancer; 2013 Feb; 119(3):540-7. PubMed ID: 22914978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy-A single-institution experience.
    Yang GL; Zhang LH; Liu Q; Wang ZL; Duan XH; Huang YR; Bo JJ
    Urol Oncol; 2017 Feb; 35(2):38.e9-38.e15. PubMed ID: 28040419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy induced reversible posterior leukoencephalopathy syndrome.
    Connolly RM; Doherty CP; Beddy P; O'Byrne K
    Lung Cancer; 2007 Jun; 56(3):459-63. PubMed ID: 17316891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.
    Türkölmez K; Bedük Y; Baltaci S; Göğüş C; Göğüş O
    Eur Urol; 2003 Dec; 44(6):682-6. PubMed ID: 14644120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin.
    Cherniawsky H; Merchant N; Sawyer M; Ho M
    Medicine (Baltimore); 2017 Feb; 96(8):e5850. PubMed ID: 28225482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy-related posterior reversible leukoencephalopathy syndrome.
    Bhatt A; Farooq MU; Majid A; Kassab M
    Nat Clin Pract Neurol; 2009 Mar; 5(3):163-9. PubMed ID: 19262592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy for primary adenocarcinomas of the urinary bladder: a single-site experience.
    Yu B; Zhou J; Cai H; Xu T; Xu Z; Zou Q; Gu M
    BMC Urol; 2015 Jan; 15(1):3. PubMed ID: 25631709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.
    Dash A; Pettus JA; Herr HW; Bochner BH; Dalbagni G; Donat SM; Russo P; Boyle MG; Milowsky MI; Bajorin DF
    Cancer; 2008 Nov; 113(9):2471-7. PubMed ID: 18823036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant gemcitabine and cisplatin: another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer.
    Nielsen ME
    Cancer; 2008 Nov; 113(9):2379-81. PubMed ID: 18823035
    [No Abstract]   [Full Text] [Related]  

  • 33. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
    Singer S; Grommes C; Reiner AS; Rosenblum MK; DeAngelis LM
    Oncologist; 2015 Jul; 20(7):806-11. PubMed ID: 26032137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modern chemotherapy of invasive bladder cancer].
    Géczi L
    Magy Onkol; 2007; 51(2):133-8. PubMed ID: 17660869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
    Galsky MD; Pal SK; Chowdhury S; Harshman LC; Crabb SJ; Wong YN; Yu EY; Powles T; Moshier EL; Ladoire S; Hussain SA; Agarwal N; Vaishampayan UN; Recine F; Berthold D; Necchi A; Theodore C; Milowsky MI; Bellmunt J; Rosenberg JE;
    Cancer; 2015 Aug; 121(15):2586-93. PubMed ID: 25872978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy.
    Ozkan A; Hakyemez B; Ozkalemkas F; Ali R; Ozkocaman V; Ozcelik T; Taskapilioglu O; Altundal Y; Tunali A
    Neuroradiology; 2006 Dec; 48(12):887-92. PubMed ID: 16983525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract.
    Song YS; Cho JS; Cho KS; Doo SH; Chung BH; Kim SJ; Yang WJ; Song KH; Kim CI; Hong SJ
    Urol Int; 2010; 85(1):47-51. PubMed ID: 20234122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
    Murasawa H; Koie T; Ohyama C; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Iwabuchi I; Ogasawara M; Kawaguchi T
    Int J Clin Oncol; 2017 Feb; 22(1):159-165. PubMed ID: 27534866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer.
    Jin JO; Lehmann J; Taxy J; Huo D; Stöckle M; Vogelzang NJ; Steinberg G; Stadler WM
    Clin Genitourin Cancer; 2006 Sep; 5(2):150-4. PubMed ID: 17026804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Metastatic micropapillary variant of urothelial carcinoma of the urinary bladder responding to gemcitabine and cisplatin chemotherapy].
    Ishii T; Matsubara T; Taira H; Hiratsuka Y
    Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):540-4. PubMed ID: 23819368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.